Uterus TA probe positioning for longitudinal scan

Uterus sagittal us image
 Uterus TA probe positioning for longitudinal scan. Uterus sagittal US image.
Uterus TA probe positioning for transverse scan

Transverse uterus

Uterus TA probe positioning for transverse scan.  Trans abdominal view of the uterus: transverse. Both ovaries are visible (not always the case).
Transvaginal Technique for Anteverted Uterus:Anteverted uterus: Align the probe in the anterior fornix. Normal TV image anteverted sagittal
Transvaginal Technique Anteverted uterus.

Normal TV image anteverted sagittal.

The overall uterine length is evaluated in the long axis from the fundus to the cervix (external os). The depth (AP diameter) is measured from the anterior to the posterior wall and perpendicular to the length.

Retroverted Uterus Transvaginal technique:If the uterus is retroverted, advance the transducer into the posterior fornix. Retroverted uterus transvaginal scan.
Retroverted transvaginal technique hl. Retroverted uterus transvaginal scan.



Evaluation of contour changes, variations in echogenicity, masses and cysts. Any pathology must be measured in 2 planes. Fibroids should be labelled if they are submucosal,intramural,subserosal or pedunculated and there position within the uterus (Rt,Lt,Midline,Fundal,Body or cervical)




 Uterus Width
The probe is turned slowly anticlockwise to visualise the uterus at 90degrees to the sagittal view.The Maximum Width is measured in this transverse (coronal) plane.




Assess the endometrial status and measure the thickness: <10mm pre menopausal; <4mm post menopause or  <6mm if post menopausal on HRT


 ENDOMETRIUM DAY 8  Late menstrual stage endometrium
Sagittal US image of the uterus obtained during the proliferative phase of the menstrual cycle demonstrates the endometrium with a multilayered appearance Normal premenopausal endometrium. Sagittal US image of the uterus obtained during the secretory phase of the menstrual cycle shows a thickened, echogenic endometrium


IUCD (Intrauterine Contraceptive Device)

The copper IUD

The copper IUD is a small plastic device with copper wire wrapped around it and a fine nylon string attached to the end. When the IUD is in place, the string comes out through the cervix into the top of the vagina.

The hormonal (Mirena) IUD

The hormonal (Mirena) IUD is a small plastic ‘T-shaped’ device that contains progestogen. This is a synthetic version of the natural hormone progesterone. The device has a coating (membrane) that controls the release of the progestogen into the uterus. Like the copper IUD, it has a fine nylon string attached to the end to make checking and removing it easier. The hormonal IUD is available in Australia under the brand name Mirena.


Ultrasound is routinely used to check the position .


 Normal positioning IUCD  String in the cervix
IUCD is seen here approximately 1.5cm from the end of the uterine fundus.
The string is seen correctly positioned in the cervical canal.


"C" Plane

The coronal plane can improve visualisation of the uterine shape and the endometrium. Congenital abnormalities can be diagnosed more confidently. Fibroids and polyps are much easier to visualise. Cornual ectopics can also be better appreciated.

It is displayed by gaining a good 2D image and rendering it into 3D images.

 Coronal Plane Endometrium

This is a rendered 3D image using a Transvaginal approach.
Coronal 3D image of a Mirena IUD shows the expected location of the shaft and crossbars simultaneously in the body and fundus of the uterus. The endometrium is also seen well without the normal shadowing of the mirena always seen in the sagittal plane.
The string can be difficult to identify on the 3D in the cervix but a 2D sagittal scan should easily show its plecement.




  • To examine the uterus, ovaries, cervix, vagina and adnexae.
  • Classification of a mass identified on other modalities eg solid, cystic, mixed.
  • Post surgical complications eg abscess, oedema.
  • Guidance of injections, aspiration or biopsy.
  • Assistance with IVF.
  • To identify the relationship of normal anatomy and pathology to each other.


  • P/V bleeding/discharge
  • Menorrhagia
  • Metrorrhagia (irregular uterine bleeding)
  • Polymenorrhea
  • Menometrorrhagia (excessive irregular bleeding)
  • Amenorrhea
  • Oligomenorrhea
  • Pelvic pain
  • Dysmenorrhea (Painful Menses)
  • F/H uterine or ovarian Cancer
  • Palpable lump
  • Infertility- primary or secondary (evaluation,monitoring and/or treatment)
  • Anomalies/evaluation
  • Follow-up of previous abnormality
  • Precocious Puberty,delayed menses or vaginal bleeding in a prepubertal child.
  • postmenopausal bleeding
  • Signs/symptoms of pelvic infection
  • IUCD Localisation (intrauterine contraceptive Device)
  • Guidance for interventional or surgical procedures
  • urinary incontinence or pelvic organ prolapse


  • Transvaginal scanning is contra-indicated if the patient is not yet sexually active or cannot provide informed consent.
  • Large patient habitus will reduce detail, particularly via the transabdominal approach.
  • Excessive bowel gas can obscure the ovaries.
  • Patients who are unsuitable for transvaginal scanning but canot adequately fill their bladder for an acoustic transabdominal window.


  • Transabdominal approach initially. Use the highest frequency probe to gain adequate penetration. This will be between a 2-7MHz range curved linear array or sector probe with Colour Doppler capabilities.
  • Transvaginal probe 4-7MHz.
  • A curved linear array probe can be used via the perineum to assess the vagina.Cover the probe.




    • If possible, scan the patient in the first 10 days of the cycle. Preferably Day 5-10 for improved diagnostic accuracy in the assessment of the endometrium and ovaries.
    • A full bladder is required . Instruct the patient to drink 1 Litre of water to be finished 1 hour before and they cannot empty their bladder before the scan.

The patient empties their bladder before the transvaginal scan is started. 




This is a generalised overview to identify the cervix, uterus and ovaries.

  1. Check for the orientation the uterus (anteverted V's retroverted)
  2. Assess the uterine size and shape.
  3. Assess the myometrium
  4. Assess the endometrial status and measure the thickness: <10mm pre menopausal; <4mm post menopause or ,<6mm if post menopausal on HRT
  5. Assess the cervix
  6. Look for free fluid in the pouch of douglas
  7. Check the ovaries and adnexae
  8. Assess bladder

Scan sagitally in the midline immediately above the pubis. Heel the probe to get the bladder over the fundus of the uterus. In this plane you should be able to assess the uterus, vagina and cervix. Zoom the image to assess and measure the endometrial thickness. Rotate into transverse and angle slightly cranially to be perpendicular to the uterus.  Whilst in transverse and slightly right of midline, angle left laterally to identify the left ovary using the full bladder as an acoustic window. Examine the ovary in two planes. Now repeat this for the right ovary.



  • Before letting the patient empty their bladder, show them the TV probe and explain the procedure. Indicate the length that is inserted which is approximately the length of a standard tampon. Explain there is no speculum used. Explain the importance of a TV scan because it is the gold standard in gynaecological ultrasound because of its superior accuracy and improved diagnostic resolution.
  • Cover the probe with a latex free TV sheath and lubricate with sterile gel on the outside.
  • Elevate the patients bottom on a thick sponge/pillow to assist the scan. A gynae ultrasound couch which drops down is ideal so that a better angulation is achieved for an anteverted uterus.
  • Ensure the patient is ready and get permission before inserting the probe.
  • If there is some resistance as the probe is being inserted, offer for the patient to help guide the probe in far enough to see the end of the fundus.
  • Keep asking the patient if they are okay.
  • When manouvering the probe to visualise the adnexae, withdraw slightly then angle the probe towards the fornix. This avoids unnecessary patient discomfort against the cervix.


Departmental and National Policies should be adhered to.







  • Gartners duct cyst
  • Vaginal carcinoma
  • Hydro/haematocolpos (secondary to imperforate hymen or vaginal stenosis)
  • Foreign body


  • Nabothian (retention) cysts
  • Polyps
  • Cervical fibroids
  • Cervical carcinoma
  • Cervical stenosis


  • Fibroids (leiomyoma)
    • submucosal
    • intramural
    • subserosal
    • pedunculated
  • Leiomyosarcoma
  • Adenomyosis
  • Lipoleiomyoma


  • Endometrial Polyps
  • Endometrial Carcinoma
  • Endomtrial hyperplasia
  • Endometritis
  • Cystic hyperplasia secondary to Tamoxifen
  • Adhesions- Ashermans Syndrome
  • Submucosal fibroids
  • Arterio-venous malformation (AVM)
  • Hydro/haematometra
  • Blood/fluid/infection or retained products of conception (RPOC)
For Uterine Pathology



  • Ovarian cysts
    • simple Vs complex (haemorrhagic, corpus luteal, ruptured, septated).
    • any mural nodules
  • Dermoid
  • Ovarian tumours:
    • Cystadenoma (serous/mucinous)-Benign
    • Cystadenocarcinoma (serous/mucinous)-Malignant
  • Polycystic Ovarian Disease
  • Endometrioma
  • Torsion
  • Hyperstimulation syndrome
  • Ectopic pregnancy
For Ovarian Pathology



  • Fluid
  • Pus
  • Blood
  • Pelvic inflammatory disease-PID (may be indicated by above conditions)
  • Cysts (Mesenteric)
  • Ectopic pregnancy
  • Endometriosis
  • Pelvic venous congestion
  • Bowel pathology may be seen (but cannot be excluded)


  • PID
  • Pyosalpynx
  • Hydrosalpynx
  • Ectopic pregnancy
  • Cyst
  • Endometriosis
Embryology of the Uterus  


Bladder and Bowel should also be examined.



A pelvic series should include the following minimum images;

  • Uterus - longitudinal, transverse (with measurements)
  • Endometrial thickness measured in the longitudinal plane
  • Cervix
  • Both ovaries- longitudinal, transverse
  • Both adnexae
  • Document the normal anatomy. Any pathology found in 2 planes, including measurements and any vascularity.


  • Garel L, Dubois J, Grignon A, Filiatrault D, Van Vliet G. US of

the pediatric female pelvis: a clinical perspective. Radiographics

2001; 21:1393–1407.

  •  Ascher SM, Imaoka I, Lage JM. Tamoxifen-induced uterine

abnormalities: the role of imaging. Radiology 2000; 214:29–38.

  •  Bree RL, Bowerman RA, Bohm-Velez M, et al. US evaluation

of the uterus in patients with postmenopausal bleeding:

A positive effect on diagnostic decision making. Radiology

2000; 216:260–264.

  •  Nalaboff KM, Pellerito JS, Ben-Levi E. Imaging the endometrium:

disease and normal variants. Radiographics 2001;


  • Fong K, Kung R, Lytwyn A, et al. Endometrial evaluation with

transvaginal US and hysterosonography in asymptomatic

postmenopausal women with breast cancer receiving

tamoxifen. Radiology 2001; 220:765–773.

  • Benacerraf BR, Shipp TD, Bromley B. Which patients benefit

from a 3D reconstructed coronal view of the uterus added

to standard routine 2D pelvic sonography? AJR Am

J Roentgenol 2008; 190:626–629.

  • Kaakaji Y, Nghiem HV, Nodell C, Winter TC. Sonography of

obstetric and gynecologic emergencies, part II: gynecologic

emergencies. AJR Am J Roentgenol 2000; 174:651–656.

Laing FC, Brown DL, DiSalvo DN. Gynecologic ultrasound.

Radiol Clin North Am 2001; 39:523–540.

  • Polat P, Suma S, Kantarcý M, Alper F, Levent A. Color Doppler

US in the evaluation of uterine vascular abnormalities.

Radiographics 2002; 22:47–53.

  • http://www.asum.com.au/newsite/files/documents/policies/PS/B2_policy.pdf
  • http://www.aium.org/resources/guidelines/reproductiveMed.pdf



Download USP on the app store

Login|View Cart|Email|Print

Download USP on the app store


© Copyright 2014 Ultrasoundpaedia

Preloaded imagePreloaded imagePreloaded imagePreloaded imagePreloaded imagePreloaded imagePreloaded imagePreloaded imagePreloaded image